The gut resistome as a potential determinant of immunotherapy response: antibiotics, immunometabolism, and precision oncology
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, yet their efficacy can be compromised by systemic antibiotic exposure and the resulting disruption of the gut microbiome. Across several tumor types, antibiotic use near the initiation of ICI therapy has frequently been associated...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2026-07-01
|
| Colección: | Frontiers in Microbiology |
| Materias: | |
| Acceso en línea: | https://www.frontiersin.org/articles/10.3389/fmicb.2026.1835588/full |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|